Page 877«..1020..876877878879..890900..»

The US and Britain indicated chronic diseases cause of death in COVID-19. One of the Russians most at risk – Wire News Fax

Posted: Published on May 2nd, 2020

the United States and Britain indicated chronic diseases cause of death in COVID-19 Pixabay.com Doctors based on the analysis of data on causes of death of hospitalized patients with positive tests COVID-19, find out what diseases most increase the risk of death in the coronavirus. statistics of deaths, published in the United States, great Britain, Italy, the Netherlands and China showed that almost half who died had one or more chronic diseases. Most often, patients suffered from cardiovascular diseases (ischemic heart disease, hypertension), chronic lower respiratory disease (asthma, chronic obstructive pulmonary disease (COPD), suffered from diabetes and dementia. Continue reading →

Posted in Coronary Heart Diseases | Comments Off on The US and Britain indicated chronic diseases cause of death in COVID-19. One of the Russians most at risk – Wire News Fax

Parents Warned to Be Vigilant as Rare Inflammatory Symptoms Strike Kids With COVID-19 – News Info Park

Posted: Published on May 2nd, 2020

Children have largely been spared the worst of COVID-19, but there may be a rare complication an inflammatory syndrome that one doctor described as causing patients to feel like every blood vessel in the body is on fire. Britains National Health Service first sounded the alarm over the weekend, warning about a small rise in children infected with the coronavirus that have overlapping features of toxic shock syndrome and atypical Kawasaki disease Continue reading →

Posted in Pediatric Cardiology | Comments Off on Parents Warned to Be Vigilant as Rare Inflammatory Symptoms Strike Kids With COVID-19 – News Info Park

Pediatric Interventional Cardiology Devices Production Declines, However Covid-19 Pandemic May Bring Back Demand in Long Term Cole Reports – Cole of…

Posted: Published on May 2nd, 2020

The continuing spread of Coronavirus (COVID-19) amongst major global economies has become an important factor of concern for import and export activities. Learn how companies in the Pediatric Interventional Cardiology Devices market are responding to the Coronavirus crisis by gaining efficacy in alternative strategies that are stabilizing various business activities. Browse through our latest research analysis on COVID-19 and its impact over the global market landscape. Continue reading →

Posted in Pediatric Cardiology | Comments Off on Pediatric Interventional Cardiology Devices Production Declines, However Covid-19 Pandemic May Bring Back Demand in Long Term Cole Reports – Cole of…

How Many People Will One Positive COVID-19 Case Infect? – Blog for Iowa

Posted: Published on May 2nd, 2020

Based on observed behavior, it seems plausible that many, many Americans still do not understand what exponential growth is. It seems like many people think that if they are infected, they will only spread the disease to others they happen to come in contact with. They seem to not realize or think about the fact that the people they infect are then going to infect others and on and on Continue reading →

Posted in Pediatric Cardiology | Comments Off on How Many People Will One Positive COVID-19 Case Infect? – Blog for Iowa

Duchenne Muscular Dystrophy Treatment Market Growth Opportunities, Challenges, Key Companies, Drivers and Forecast to 2026 Cole Reports – Cole of…

Posted: Published on May 2nd, 2020

Pharmacia & Upjohn LLC Global Duchenne Muscular Dystrophy Treatment Market: Competitive Landscape This section of the report lists various major manufacturers in the market. The competitive analysis helps the reader understand the strategies and collaborations that players focus on in order to survive in the market Continue reading →

Posted in Muscular Dystrophy Treatment | Comments Off on Duchenne Muscular Dystrophy Treatment Market Growth Opportunities, Challenges, Key Companies, Drivers and Forecast to 2026 Cole Reports – Cole of…

Vertex Receives European CHMP Positive Opinion for KALYDECO (ivacaftor) for Children and Adolescents With Cystic Fibrosis Between the Ages 6 Months…

Posted: Published on May 2nd, 2020

- If approved, KALYDECO (ivacaftor) will be the first and only medicine in Europe to treat the underlying cause of cystic fibrosis in patients with the R117H mutation, the most common residual function mutation, as young as 6 months of age - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the European Medicines Agencys (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the label extension of KALYDECO (ivacaftor), to include the treatment of children and adolescents with cystic fibrosis (CF), ages 6 months and older weighing at least 5 kg who have the R117H mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Continue reading →

Posted in Muscular Dystrophy Treatment | Comments Off on Vertex Receives European CHMP Positive Opinion for KALYDECO (ivacaftor) for Children and Adolescents With Cystic Fibrosis Between the Ages 6 Months…

EMA warns against unproven therapies – English – Agenzia ANSA

Posted: Published on May 2nd, 2020

(ANSA) - Rome, April 29 - The European Medicines Agency (EMA) has sounded the alarm about the use of cell-based therapies that are promoted as being miracle cures but, in fact, are often unproven and unauthorized. Serious Risks. Continue reading →

Posted in Muscular Dystrophy Treatment | Comments Off on EMA warns against unproven therapies – English – Agenzia ANSA

Vertex Pharmaceuticals and Affinia Therapeutics Establish Multi-Year Collaboration to Discover and Develop Novel AAV Capsids for Genetic Therapies -…

Posted: Published on May 2nd, 2020

BOSTON & WALTHAM, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq:VRTX) and Affinia Therapeutics announced today that the two companies have entered into a strategic research collaboration to engineer novel adeno-associated virus (AAV) capsids to deliver transformative genetic therapies to people with serious diseases. Affinia Therapeutics proprietary AAVSmartLibrary and associated technology provides capsids for improved tissue tropism, manufacturability and pre-existing immunity Continue reading →

Posted in Muscular Dystrophy Treatment | Comments Off on Vertex Pharmaceuticals and Affinia Therapeutics Establish Multi-Year Collaboration to Discover and Develop Novel AAV Capsids for Genetic Therapies -…

Green Bay-area woman charged with hiding 5-year-old son’s corpse, says she gave him CBD to treat seizures – The Sheboygan Press

Posted: Published on May 1st, 2020

Hussein(Photo: Courtesy of the Brown County Jail) GREEN BAY - A5-year-old boy whose body was found in the trunk of his mom'scar March 30 had died months earlier, authorities said. Sagal A. Hussein, 25, of Howard was charged Thursday with hiding her son Josias Marquez's body in her car,as new court documents reveal shocking details about the allegations against her and previous reports of neglect Continue reading →

Posted in Cerebral Palsy Treatment | Comments Off on Green Bay-area woman charged with hiding 5-year-old son’s corpse, says she gave him CBD to treat seizures – The Sheboygan Press

Wisconsin woman charged after sons body found in her car – WITI FOX 6 Milwaukee

Posted: Published on May 1st, 2020

Sagal Hussein (PHOTOS: WLUK) GREEN BAY, Wis. A Wisconsin woman is charged after the body of her young son was found in her car apparently months after he died. Continue reading →

Posted in Cerebral Palsy Treatment | Comments Off on Wisconsin woman charged after sons body found in her car – WITI FOX 6 Milwaukee

Page 877«..1020..876877878879..890900..»